107 related articles for article (PubMed ID: 18506105)
1. Endotoxin-binding affinity of sevelamer hydrochloride.
Perianayagam MC; Jaber BL
Am J Nephrol; 2008; 28(5):802-7. PubMed ID: 18506105
[TBL] [Abstract][Full Text] [Related]
2. Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study.
Sun PP; Perianayagam MC; Jaber BL
J Ren Nutr; 2009 Sep; 19(5):432-8. PubMed ID: 19464926
[TBL] [Abstract][Full Text] [Related]
3. Novel dosage forms and regimens for sevelamer-based phosphate binders.
Duggal A; Hanus M; Zhorov E; Dagher R; Plone MA; Goldberg J; Burke SK
J Ren Nutr; 2006 Jul; 16(3):248-52. PubMed ID: 16825030
[TBL] [Abstract][Full Text] [Related]
4. Sevelamer hydrochloride exacerbates metabolic acidosis in hemodialysis patients, depending on the dosage.
Oka Y; Miyazaki M; Takatsu S; Kunitomo K; Uno F; Maruyama M; Matsuda H
Ther Apher Dial; 2007 Apr; 11(2):107-13. PubMed ID: 17381531
[TBL] [Abstract][Full Text] [Related]
5. Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications.
Pai AB; Shepler BM
Pharmacotherapy; 2009 May; 29(5):554-61. PubMed ID: 19397463
[TBL] [Abstract][Full Text] [Related]
6. Kinetic and thermodynamic evaluation of phosphate ions binding onto sevelamer hydrochloride.
Elsiddig R; Hughes H; Owens E; O' Reilly NJ; O'Grady D; McLoughlin P
Int J Pharm; 2014 Oct; 474(1-2):25-32. PubMed ID: 25102115
[TBL] [Abstract][Full Text] [Related]
7. Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia.
Hauser AB; Azevedo IR; Gonçalves S; Stinghen A; Aita C; Pecoits-Filho R
Blood Purif; 2010; 30(3):153-8. PubMed ID: 20861617
[TBL] [Abstract][Full Text] [Related]
8. Relative in vitro efficacy of the phosphate binders lanthanum carbonate and sevelamer hydrochloride.
Autissier V; Damment SJ; Henderson RA
J Pharm Sci; 2007 Oct; 96(10):2818-27. PubMed ID: 17497733
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Gastric pH, sevelamer hydrochloride and omeprazole.
Capitanini A; Lupi A; Osteri F; Petrone I; Del Corso C; Straniti M; Gallieni M; Rossi A
Clin Nephrol; 2005 Oct; 64(4):320-2. PubMed ID: 16240906
[TBL] [Abstract][Full Text] [Related]
11. The effects of CO2 on cytokine concentrations in endotoxin-stimulated human whole blood.
Kimura D; Totapally BR; Raszynski A; Ramachandran C; Torbati D
Crit Care Med; 2008 Oct; 36(10):2823-7. PubMed ID: 18766096
[TBL] [Abstract][Full Text] [Related]
12. Nonphosphate-binding effects of sevelamer--are they of clinical relevance?
Marangon N; Lindholm B; Stenvinkel P
Semin Dial; 2008; 21(5):385-9. PubMed ID: 18573137
[TBL] [Abstract][Full Text] [Related]
13. The influence of poly(allylamine hydrochloride) hydrogel crosslinking density on its thermal and phosphate binding properties.
Elsiddig R; O'Reilly NJ; Hudson SP; Owens E; Hughes H; O'Grady D; McLoughlin P
Int J Pharm; 2022 Jun; 621():121806. PubMed ID: 35526696
[TBL] [Abstract][Full Text] [Related]
14. Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism.
Sun PP; Perianayagam MC; Jaber BL
Kidney Int Suppl; 2009 Dec; (114):S20-5. PubMed ID: 19946323
[TBL] [Abstract][Full Text] [Related]
15. Buffering effects of calcium carbonate as clarified by sevelamer hydrochloride monotherapy.
Akatsuka T; Mochizuki T; Koike T
Ther Apher Dial; 2008 Jun; 12(3):216-25. PubMed ID: 18503699
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling studies of the binding characteristics of phosphates to sevelamer hydrochloride--assessing a novel technique to reduce phosphates contamination.
Parker R; Odukale AA; Fisher D; Batich C; Ross E; Edwards J
Int J Environ Res Public Health; 2006 Jun; 3(2):202-8. PubMed ID: 16823094
[TBL] [Abstract][Full Text] [Related]
17. Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients on sevelamer hydrochloride: which dialysate calcium concentration to use?
Sonikian M; Metaxaki P; Karatzas I; Vlassopoulos D
Blood Purif; 2009; 27(2):182-6. PubMed ID: 19141997
[TBL] [Abstract][Full Text] [Related]
18. Effect of sevelamer hydrochloride on bone in experimental uremic rats.
Kuwahara M; Inoshita S; Terada Y; Sasaki S
Ther Apher Dial; 2009 Feb; 13(1):42-8. PubMed ID: 19379169
[TBL] [Abstract][Full Text] [Related]
19. Determination of the binding parameter constants of Renagel capsules and tablets at pH 7 by high performance capillary electrophoresis.
Swearingen RA; Zhorov E; Cohen A; Sybertz T; Barry EF
J Pharm Biomed Anal; 2004 Jun; 35(4):753-60. PubMed ID: 15193719
[TBL] [Abstract][Full Text] [Related]
20. A phosphate binding assay for sevelamer hydrochloride by ion chromatography.
Mazzeo JR; Peters RM; Hanus MR; Chen X; Norton KA
J Pharm Biomed Anal; 1999 May; 19(6):911-5. PubMed ID: 10698557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
